Robert C Merton - Net Worth and Insider Trading

Robert C Merton Net Worth

The estimated net worth of Robert C Merton is at least $272 dollars as of 2024-03-28. Robert C Merton is the Director of Fresh Tracks Therapeutics Inc and owns about 303 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $272. Details can be seen in Robert C Merton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert C Merton has not made any transactions after 2017-11-10 and currently still holds the listed stock(s).

Transaction Summary of Robert C Merton

To

Robert C Merton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert C Merton owns 1 companies in total, including Fresh Tracks Therapeutics Inc () .

Click here to see the complete history of Robert C Merton’s form 4 insider trades.

Insider Ownership Summary of Robert C Merton

Ticker Comapny Transaction Date Type of Owner
Fresh Tracks Therapeutics Inc 2017-11-10 director

Robert C Merton Latest Holdings Summary

Robert C Merton currently owns a total of 1 stock. Robert C Merton owns 303 shares of Fresh Tracks Therapeutics Inc (FRTX) as of November 10, 2017, with a value of $272.

Latest Holdings of Robert C Merton

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FRTX Fresh Tracks Therapeutics Inc 2017-11-10 303 0.90 272

Holding Weightings of Robert C Merton


Robert C Merton Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert C Merton has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 272 shares on November 10, 2017, which cost Robert C Merton around $149,975.

Insider Trading History of Robert C Merton

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert C Merton Trading Performance

GuruFocus tracks the stock performance after each of Robert C Merton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert C Merton is -19.07%. GuruFocus also compares Robert C Merton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert C Merton within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert C Merton's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert C Merton

Average Relative Return

-30%

Average relative return per transaction

Outperforming Transactions

25%

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -1.44 -19.07 -32.56 -30 -47.65 -47.92
Relative Return to S&P 500(%) -2.57 -21.94 -40.08 -46.31 -62.35 -59.78

Robert C Merton Ownership Network

Ownership Network List of Robert C Merton

No Data

Ownership Network Relation of Robert C Merton


Robert C Merton Owned Company Details

What does Fresh Tracks Therapeutics Inc do?

Who are the key executives at Fresh Tracks Therapeutics Inc?

Robert C Merton is the director of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .

Fresh Tracks Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Robert C Merton made no insider transaction in Fresh Tracks Therapeutics Inc (). Other recent insider transactions involving Fresh Tracks Therapeutics Inc () include a net sale of 110 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc () in total and bought 264,139 shares, with a net purchase of 264,139 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc () were sold and 311,139 shares were bought by its insiders, resulting in a net purchase of 311,029 shares.

Fresh Tracks Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fresh Tracks Therapeutics Inc Insider Transactions

No Available Data

Robert C Merton Mailing Address

Above is the net worth, insider trading, and ownership report for Robert C Merton. You might contact Robert C Merton via mailing address: 10390 Pacific Center Court, San Diego Ca 92121.

Discussions on Robert C Merton

No discussions yet.